Safety/Efficacy Study of Retigabine vs. Placebo in Post-Herpetic Neuralgia (PHN)

Summary

The purpose of the study is to evaluate the efficacy of retigabine vs. placebo in reducing pain associated with post-herpetic neuralgia.

Timeline

Start

2007-10

Primary completion

2009-05

Completion

2009-12

Outcome

Missed primary endpoint

registry Retigabine vs 2: Placebo; p = 0.2537; Mean Difference (Net) -0.43 (95% CI -1.171 to 0.312); ANCOVA NCT00612105 ↗

Drugs

Indications